Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 12, 2012, Pages 1430-1437

  Karkouche, Raymond ^a,b   Bachet, Jean Baptiste ^a,b,f   Sandrini, Jeremy ^c   Mitry, Emmanuel ^a,b,g   Penna, Christophe ^a,b,h   Côté, Jean François ^a,b   Blons, Hélène ^d   Penault Llorca, Frédérique ^e   Rougier, Philippe ^a,b,d   Saint André, Jean Paul ^c   Emile, Jean François ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e CENTRE JEAN PERRIN   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g INSTITUT CURIE   (France)

^h BICÊTRE HOSPITAL   (France)

Author keywords

BRAF; colorectal cancer; KRAS; neuroendocrine tumor; oncogenesis

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CARCINOMA; COLORECTAL NEUROENDOCRINE CARCINOMA; DISEASE COURSE; DRUG RESPONSE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MALE; NEUROENDOCRINE TUMOR; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE BRAF; ONCOGENE K RAS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NEUROENDOCRINE; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS, FUSION; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RETROSPECTIVE STUDIES; RNA, MESSENGER; TIME FACTORS; TREATMENT OUTCOME;

EID: 84869441872     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283583c87     Document Type: Article

References (46)

1. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008; 9:61-72.
2. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128:1717-1751.
3. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. Lyon, France: World Health Organization, International Agency for Research of Cancer; 2010.
4. Rindi G, Klöppel G, Couvelard A, Komminoth P, Körner M, Lopes JM, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007; 451:757-762.
5. Capella C, La Rosa S, Uccella S, Billo P, Cornaggia M. Mixed endocrineexocrine tumors of the gastrointestinal tract. Semin Diagn Pathol 2000; 17:91-103.
6. Lewin K. Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 1987; 11 (Suppl 1):71-86.
7. Rosa SL, Marando A, Sessa F, Capella C. Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update. Cancers 2012; 4:11-30.
8. Pecorella I, Memeo L, Ciardi A, H Rotterdam. An unusual case of colonic mixed adenoendocrine carcinoma: collision versus composite tumor. A case report and review of the literature. Ann Diagn Pathol 2007; 11:285-290.
9. Demellawy El D, Khalifa MA, Ismiil N,Wong S, Ghorab Z. Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases. Diagn Pathol 2007; 2:35.
10. Makino A, Serra S, Chetty R. Composite adenocarcinoma and large cell neuroendocrine carcinoma of the rectum. Virchows Arch 2006; 448: 644-647.
11. Ihtiyar E, Algin C, Isiksoy S, Ates E. Small cell carcinoma of rectum: a case report. World J Gastroenterol 2005; 11:3156-3158.
12. Anagnostopoulos GK, Arvanitidis D, Sakorafas G, Pavlakis G, Kolilekas L, Arkoumani E, et al. Combined carcinoid-adenocarcinoma tumour of the anal canal. Scand J Gastroenterol 2004; 39:198-200.
13. Jiao YF, Nakamura SI, Arai T, Sugai T, Uesugi N, Habano W, et al. Adenoma, adenocarcinoma and mixed carcinoid-adenocarcinoma arising in a small lesion of the colon. Pathol Int 2003; 53:457-462.
14. Furlan D, Cerutti R, Genasetti A, Pelosi G, Uccella S, La Rosa S, et al. Microallelotyping defines the monoclonal or the polyclonal origin of mixed and collision endocrine-exocrine tumors of the gut. Lab Invest 2003; 83:963-971.
15. Yagihashi N, Koyama M, Yagihashi S. Rectal adenocarcinoid with lymph node metastasis. Pathol Int 1999; 49:563-565.
16. Mándoky L. Amphicrine tumor. Pathol Oncol Res 1999; 5:239-244.
17. Lyda MH, Fenoglio-Preiser CM. Adenoma-carcinoid tumors of the colon. Arch. Pathol Lab Med 1998; 122:262-265.
18. Sigel JE, Goldblum Jr. Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases. Mod Pathol 1998; 11:537-542.
19. Onishi R, Sano T, Nakamura Y, Namiuchi S, Sawada S, Ihara C, et al. Ectopic adrenocorticotropin syndrome associated with undifferentiated carcinoma of the colon showing multidirectional neuroendocrine, exocrine, and squamous differentiation. Virchows Arch 1996; 427:537-541.
20. Hock YL, Scott KW, Grace RH. Mixed adenocarcinoma/carcinoid tumour of large bowel in a patient with Crohn's disease. J Clin Pathol 1993; 46: 183-185.
21. Burke AB, Shekitka KM, Sobin LH. Small cell carcinomas of the large intestine. Am J Clin Pathol 1991; 95:315-321.
22. Sarsfield P, Anthony PP. Small cell undifferentiated ('neuroendocrine') carcinoma of the colon. Histopathology 1990; 16:357-363.
23. Levendoglu H, Cox CA, Nadimpalli V. Composite (adenocarcinoid) tumors of the gastrointestinal tract. Dig Dis Sci 1990; 35:519-525.
24. Gaffey MJ, Mills SE, Lack EE. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases. Am J Surg Pathol 1990; 14:1010-1023.
25. Moyana TN, Qizilbash AH, Murphy F. Composite glandular-carcinoid tumors of the colon and rectum. Report of two cases. Am J Surg Pathol 1988; 12:607-611.
26. Wick MR,Weatherby RP,Weiland LH. Small cell neuroendocrine carcinoma of the colon and rectum: clinical, histologic, and ultrastructural study and immunohistochemical comparison with cloacogenic carcinoma. Hum Pathol 1987; 18:9-21.
27. Knight BK, Hayes MM. Mixed adenocarcinoma and carcinoid tumour of the colon. A report of 4 cases with postulates on histogenesis. S Afr Med J 1987; 72:708-710.
28. Gledhill A, Hall PA, Cruse JP, Pollock DJ. Enteroendocrine cell hyperplasia, carcinoid tumours and adenocarcinoma in long-standing ulcerative colitis. Histopathology 1986; 10:501-508.
29. Klappenbach RS, Kurman RJ, Sinclair CF, James LP. Composite carcinomacarcinoid tumors of the gastrointestinal tract. A morphologic, histochemical, and immunocytochemical study. Am J Clin Pathol 1985; 84:137-143.
30. Palvio DH, Sørensen FB, Kløve-Mogensen M. Stem cell carcinoma of the colon and rectum. Report of two cases and review of the literature. Dis Colon Rectum 1985; 28:440-445.
31. Peonim V, Thakerngpol K, Pacharee P, Stitnimankarn T. Adenosquamous carcinoma and carcinoidal differentiation of the colon. Report of a case. Cancer 1983; 52:1122-1125.
32. Hernandez FJ, Reid JD. Mixed carcinoid and mucus-secreting intestinal tumors. Arch Pathol 1969; 88:489-496.
33. Bates HR, Belter LF. Composite carcinoid tumor (argentaffinomaadenocarcinoma) of the colon: report of 2 cases. Dis Colon Rectum 1967; 10:467-470.
34. Li Y, Yau A, Schaeffer D, Magliocco A, Gui X, Urbanski S, et al. Colorectal glandular-neuroendocrine mixed tumor: pathologic spectrum and clinical implications. Am J Surg Pathol 2011; 35:413-425.
35. De RoockW, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G, et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 2010; 11:753-762.
36. Montagut C, Galvan A, Gallen M. ALK chromosomal alterations in colon cancer patients. J Clin Oncol 2010; 28:15.
37. Didelot A, Le Corre D, Luscan A, Cazes A, Pallier K, Emile J-F, et al. Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples. Exp Mol Pathol 2012; 92:275-280.
38. Kwak EL, Bang Y-J, Camidge DR, Shaw AT, Solomon B, Maki RG, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010; 363:1693-1703.
39. Just P-A, Cazes A, Audebourg A, Cessot A, Pallier K, Danel C, et al. Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: a comprehensive study of Caucasian non-smokers. Lung Cancer 2011; 76:309-315.
40. Shia J, Tang LH, Weiser MR, Brenner B, Adsay NV, Stelow EB, et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol 2008; 32:719-731.
41. La Rosa S, Marando A, Furlan D, Sahnane N, Capella C. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers. Am J Surg Pathol 2012; 36:601-611.
42. Carr LL, Finigan JH, Kern JA. Evaluation and treatment of patients with nonsmall cell lung cancer. Med Clin North Am 2011; 95:1041-1054.
43. Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, et al. DAXX/ ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011; 331:1199-1203.
44. Vortmeyer AO, Lubensky IA, Merino MJ,Wang CY, Pham T, Furth EE, et al. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 1997; 89:1448-1453.
45. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364:2507-2516.
46. Strosberg JR, Coppola D, Klimstra DS, Phan AT, Kulke MH, Wiseman GA, Kvols LK. North American Neuroendocrine Tumor Society (NANETS). The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas 2010; 39:799-780.